Napo Therapeutics, S.p.A.
1 clinical trials · Sponsor
◉ Watch Napo Therapeutics, S.p.A.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) (NCT06904872) | Napo Therapeutics, S.p.A. | 2025-05-29 |
Track Napo Therapeutics, S.p.A. automatically
Every clearance here is in the API, with alerts when new ones post.